Antitrust – Page 3 – Lieff Cabraser

Lieff Cabraser and Co-Counsel File Federal Antitrust Class Action Lawsuit Against Deutsche Telekom, T-Mobile US, and Softbank Group over T-Mobile/Sprint Merger

Federal lawsuit alleges American consumers have paid billions more for wireless services after one of the most anti-competitive acquisitions in history reduced the number of U.S. retail mobile carriers from four to three and combined two fierce competitors into a single behemoth with no incentive to compete CHICAGO–(BUSINESS WIRE)–On Friday, June 17, 2022, Lieff Cabraser

LieffCabraser2022-08-23T16:00:00+00:00June 17th, 2022|Antitrust|

Critical Need for New Judges with Antitrust Expertise Highlighted in NY Times Op-Ed: “When Picking Judges, Democrats Need to Stop Ignoring Economics”

The New York Times has published a powerful opinion piece by lead business and economics writer Binyamin Appelbaum, calling on President Biden to push back against corporate abuses by “putting antitrust experts on the federal bench.” The piece refers back to the massive impact then-President Reagan’s court nominations had on our justice system in the

LieffCabraser2022-06-07T23:39:00+00:00June 7th, 2022|Antitrust|

Lieff Cabraser Ranked Among Top Class Action Antitrust Law Firms in Newly-Issued 2021 Antitrust Annual Report

Lieff Cabraser recognized as one of the leading antitrust law firms named by Huntington Bank and UC Hastings Law in the recently-issued “2021 Antitrust Annual Report: Class Action Filings in Federal Court” Huntington Bank and the Center for Litigation and Courts at UC College of the Law, San Francisco have released

LieffCabraser2022-09-24T03:38:41+00:00June 6th, 2022|Antitrust|

Plaintiffs in National Drug Price-Fixing Cases Defeat Defendants’ Attempts to Get State Claims Thrown Out

As reported in Law360 (subscription), plaintiffs represented by Lieff Cabraser and co-counsel were successful in defeating defendant drug companies’ attempts to get their state-based consumer fraud claims thrown out of the large-scale multidistrict aggregate litigation alleging collusion on a national level in the pricing of a significant group of generic drugs, including clobetasol, clomipramine and

LieffCabraser2022-05-11T16:23:27+00:00May 11th, 2022|Antitrust|

DOJ Antitrust Division Announces it Will Now Require Leniency Applicants to Pay Restitution to Victims

Before receiving a final leniency letter, applicants must now actually pay restitution to the victims of the misconduct The Antitrust Division of the DOJ today announced updates to one of its primary enforcement tools, the offender leniency program, and issued a revised set of plain-language answers to frequently asked questions (FAQs) relating to the program. The

LieffCabraser2022-04-05T18:39:19+00:00April 5th, 2022|Antitrust|

Treasury Report Reveals that Collusion and Other Illegal Anticompetitive Practices by Employers Suppress Worker Pay and Job Opportunities Across the U.S.

Government’s new report shows that employers face little competition for workers, allowing companies to pay employees substantially less than a so-called “free” market would manifest A new study has been released by the U.S. government revealing that despite a purported “tight” labor market that should give workers leverage, in fact the system is deeply flawed

LieffCabraser2022-03-09T02:29:41+00:00March 9th, 2022|Antitrust, Employment Law|

Lin Chan and Dean Harvey Named Top Antitrust Lawyers in California by the Daily Journal

The Daily Journal (subscription) has named its Top Antitrust Lawyers in California for 2021, a list that includes Lieff Cabraser partners Lin Y. Chan and Dean M. Harvey. Lin and Dean are two of only twenty-seven antitrust law practitioners to make the list, and are featured in the Daily Journal’s “2021 Top Antitrust Lawyers in

LieffCabraser2021-11-17T20:14:33+00:00November 17th, 2021|Antitrust, Awards, Firm News|

Settlement Distribution From Duke/UNC “No Poach” Employee Anticompetition Lawsuit Highlights Structural Inequities in Higher Education

In August 2021, the federal court approved a $19 million settlement on behalf of thousands of faculty members at UNC-Chapel Hill and Duke to resolve a class-action lawsuit alleging the two universities illegally colluded to avoid competing to hire professors and faculty members from each other, artificially suppressing salaries and employee mobility between the two

LieffCabraser2021-11-02T21:36:40+00:00November 2nd, 2021|Antitrust, Employment Law|

UNC And Duke Faculty Receive Payments from $19 Million Settlement of Class Action Labor Antitrust “No-Poach” Lawsuit

This case on behalf of non-medical faculty follows Lieff Cabraser Heimann & Bernstein LLP’s successful similar action against Duke on behalf of medical faculty that led to a $54.5 million settlement in 2019 As reported by The News&Observer, thousands of UNC-Chapel Hill and Duke University faculty members are getting paid from Duke as part of a $19

LieffCabraser2021-11-02T18:01:17+00:00October 27th, 2021|Antitrust, Employment Law|

Allergan Will Pay Restasis Buyers $30 Million in Antitrust Class Action Lawsuit Settlement

As reported by Law360 (subscription), Allergan has agreed to pay $30 million to settle an antitrust lawsuit filed by Lieff Cabraser and co-counsel on behalf of a group of pharmaceutical purchasers, union benefit plans, and other buyers of Allergan’s blockbuster dry-eye disease drug Restasis. The sweeping litigation accused the drugmaker of

LieffCabraser2021-10-14T22:50:41+00:00October 14th, 2021|Antitrust, Firm News|